Ongoing education is critical to healthcare professionals in clinical and research settings alike to ensure they remain current on the state-of-the-art in order to deliver the best care to patients. Medical communications is the communication of scientific, medical, pharmaceutical and biotechnology information and data to various audiences. This information includes updates on the latest discoveries within a given disease area, as well as dissemination of data generated through clinical trials and health economic and outcomes research.
Medical communications encompass the development and delivery of programs that facilitate scientific exchange among doctors, pharmacists, nurses, and other stakeholders within the space, including payers, formulary decision-makers, and patient advocacy groups. Credible, evidence-based content is foundational to these programs, which are designed to deliver new information and updates to various stakeholder audiences through a variety of formats and channels.
The publication of data generated from research and clinical studies is at the core of these programs, creating peer-reviewed source references that support what is being communicated through educational programs, tools and resources that support healthcare and medical professionals.
Pharmaceutical, biotech and device companies often engage outsource partners with expertise in developing strategies and plans to complement their in-house team and help them evolve and implement core programming. These agencies provide consultative as well as tactical support across a broad range of programs – some specialize and focus on specific channels, such as publications or digital, while others provide full-service support across the medical communications spectrum.
Strategy development typically starts with in-depth assessments of the landscape, looking at disease – as well as treatment-specific literature and other publicly-available information – to gain a clear read on current thinking.
These assessments uncover topics of interest to particular audience groups, as well as gaps that could be fulfilled through medical communications programming. Using these insights, agencies collaborate with their client partners to create compelling scientific content using data generated from the client’s study programs, and help them deliver that content through engagement of specialist experts, clinical practitioners and the broader healthcare community.
Supporting companies in the pharmaceutical and healthcare industries, medical communications agencies provide advice on how to educate their particular consumer base on the risks and benefits of new products and therapies, backed up by clinical and economic data. They also provide counsel to branding and marketing teams to ensure credible and compliant delivery of core evidence-based messages through multi-channel promotional programming. To put it simply, a medical communication agency will help healthcare and pharmaceutical companies to deliver engaging clinical evidence and opinions to their target audience.
The range of services medical communications agencies provide to their clients may include any or all of the following:
Medical communications roles include a variety of account service and scientific writing functions. Clients rely upon the scientific expertise of the medical writing staff to generate compelling, credible content that is strategically aligned and accurate, and editorial groups ensure that all content adheres to medical writing standards and best practice.
Graphic and digital design teams bring scientific stories to life through visualizations and interactive platforms. Account management supports the development and implementation of all projects and programs on behalf of assigned teams, ensuring on-time delivery, efficiently and within agreed budget parameters.
The pharmaceutical and healthcare industries are highly competitive and need to stay ahead of the curve to be successful. It’s difficult to bring a new product to market, as medical regulations are becoming stricter, the economy is becoming tougher and healthcare costs continue to rise globally.
The process of researching and developing new products is also a slow one, with only a couple out of thousands of drugs developed in the laboratory becoming marketable. As such, there is a demand for medical communications prior to and after the drug approval stage. The most efficient communication plans guarantee that the right information is delivered to the relevant target audience.
Successful medical communication plans contribute to scientific exchange by ensuring stakeholders involved in the diagnosis, treatment and management of conditions and diseases are aware of the latest developments in their field. Medical communications agencies help pharmaceutical, biotech and device companies effectively translate sometimes complicated science and highlight relevance to clinical practice. This contributes to the ongoing education of healthcare professionals to help them continually improve the care they deliver to patients.
The US Forecaster’s Check List for Japan: A World of Difference
Expanding the valuation of a biopharmaceutical asset to Japan requires a new mindset in nearly every input of forecasting, with many pitfalls. Doug Willson, Senior Vice President, Cello Health Advantage and Tiffany Ahlers, Chief Commercial Officer, Mycovia Pharmaceuticals Inc., share a checklist to improve the rigor and validity of product forecasts for Japan.
Using organic and unfiltered social media data, Cello Health is proud to share with you the first in a series of reports aimed at centralizing and amplifying the authentic patient experience.
Embedding patient journeys into clinical and commercial planning, for more focused decisions and improved patient outcomes.
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us